Methicillin-resistant Staphylococcus aureus: Pediatric perspective

M. W. Kline, E. O. Mason

Research output: Contribution to journalArticlepeer-review

22 Scopus citations


Methicillin-resistant S. aureus has emerged as a nosocomial pathogen of major importance in pediatric patients. Infection occurs most often in hospitalized individuals with underlying predisposing medical conditions. Any body site may be involved, and bacteremia frequently occurs concomitantly. Vancomycin is the antibiotic of choice for serious MRSA infections; PRPs and cephalosporins generally are not effective. The likelihood of an adverse outcome of infection increases with the severity of an underlying condition and delay in institution of appropriate therapy. Infection control measures have mey with only limited success in eradicating MRSA from the hospital environment. Methicillin-resistant S. aureus is likely to remain of considerable clinical significance to physicians caring for seriously ill children.

Original languageEnglish (US)
Pages (from-to)613-624
Number of pages12
JournalPediatric Clinics of North America
Issue number3
StatePublished - 1988

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health


Dive into the research topics of 'Methicillin-resistant Staphylococcus aureus: Pediatric perspective'. Together they form a unique fingerprint.

Cite this